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• Irritable bowel syndrome (IBS) is a common chronic gastrointestinal tract disorder.
• IBS is characterized by abdominal pain or discomfort, diarrhea, constipation, bloating, and
distension in absence of identifiable biochemical or structural abnormalities.
• IBS has a prevalence of 12-20% of the adult population worldwide and more common in
women. (1)
• Pathophysiology may be multifactorial, witch is attributed to alterations in: gastrointestinal
motility, visceral hypersensitivity, intestinal microbiota, gut epithelium and immune function,
dysfunction of brain-gut axis or certain psychosocial factors.
• Recent research have revealed a potential role for the microbiota and the host immune
response in IBS.
• Probiotics are live microorganisms that have the capacity to prevent or treat specific
pathological conditions when administered in adequate amounts.
• Probiotics has been investigated as a promising treatment for IBS, and have demonstrated
beneficial effects in some patients. ( 2)
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• Systematic reviews and meta-analyzes have showed reasonable evidences that probiotics have
a beneficial effect improving the symptoms of IBS . But It needs investigation about best stains,
doses, time of treatment, use of mixtures or single probiotics and classification criteria for
patients.
• The pathophysiology of IBS need more investigation. Understanding better the mechanisms of
this disease also will do easier to find personalized treatments. For that reason, also it will be
important to study the microbiota profile in patients.
• In the short term, the most important thing is to harmonize clinical trials to obtain more
powerful results. And with them to identify probiotics that are the best candidates for
treatment.
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• Scientific literature search on PubMed database: Reviews and recent papers about
probiotics and IBS (search terms : “IBS”, “treatment”, “IBS + Probiotics”). This info was
selected according to their relevance and date.
• For being effective probiotics need five
conditions:
• (1)It must not be toxic or pathogenic
• (2) It must have a proven beneficial
effect
• (3) It must contain a sufficiently large
number of viable microorganisms,
• (4) It must be capable of surviving in
the intestine, maintaining itself and
having intraluminal metabolic activity
• (5) It must remain viable during
storage and use. (3)
• Most commonly used probiotics come
from genera Bifidobacterium and
Lactobacillus, but other species are in
trial.
• Probiotics can be used alone, or in
combination of different microorganism.
• There are many clinical trials investigating
the therapeutic benefit of probiotics in IBS
patients, but they are heterogenic in
terms of doses and species.(Table 1)
Table 1: Placebo controlled clinical trials of single or mixed probiotic 
preparations in IBS. Modified of A.Magnus et al.
Results Of Trials
• Most clinical trials have been effective in
treating the symptoms, as show the
Table 1 and Figure 2. (4)
• Some clinical trials did not show
significant effect. (Table 2)
• Only one clinical trial did show
deterioration of the symptoms.
• Current data indicate that mixture of
probiotics is more effective than singles
one.
• Although, some strains have shown
benefits for IBS when used alone( Table 2)
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Figure 2: summary of probiotics have demonstrated efficacy 
improving the symptoms of IBS.
26(81%)
5 (16%)
1(3%)
effective non-effective Deterioration of symptoms
Figure 2: Summary of results of clinical trials (table 1)
Figura 3: Mechanism of action of probiotics in IBS. Modified from A. Hosseini et al. 
Table 2:  More effective, and non-effective probiotics 
used alone.
• Most clinical trials have showed efficacy
in the treatment of IBS, but most of
them are been more effective on single
symptoms than on the entire IBS. Only
some probiotics have showed efficacy
improving the global symptoms of IBS.
It is showed in Figure 2.
• Also, as IBS is a complex and
multifactorial disease , finding a
treatment for all the symptoms, and
types of IBS, will be difficult.
• It is well known that probiotics strains have numerous positive effects in the gastrointestinal
tract.
• Mechanisms of action of probiotics in the treatment of IBS are not fully known, but actually
there are a lot of evidences and research about it. Figure 3 is a summary of all these
mechanisms which participate in the improvement of patients with IBS.
• It is increasingly evident importance between the composition of the microbiota of the host,
the immune system, the gut-brain axis and the interaction between them.
